Royersford, PA, United States of America

Eric Gould Gundersen


 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 62(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (1998 - 2006)
  • Hightstown, NJ (US) (2004 - 2009)
  • Royersford, PA (US) (2005 - 2009)

Company Filing History:


Years Active: 1998-2009

Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: The Innovative Contributions of Eric Gould Gundersen

Introduction

Eric Gould Gundersen is a prolific inventor based in Royersford, Pennsylvania. With a total of 13 patents to his name, he has made significant contributions to the field of biochemistry, particularly in the development of therapeutic compounds. His work is recognized for its potential in treating various medical conditions through innovative chemical formulations.

Latest Patents

Among Eric Gundersen's latest patents is his work on "Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)." This invention details PAI-1 inhibiting compounds characterized by a complex formula, where various functional groups can fulfill specific roles in enhancing their efficacy. Additionally, he has developed patents related to "Substituted phenyl indoles," which also serve as PAI-1 inhibitors. These innovative compounds showcase his commitment to addressing important health issues through advanced pharmaceutical research.

Career Highlights

Gundersen's career includes notable positions at Wyeth and American Home Products Corporation. His tenure at these prestigious organizations highlights his expertise and dedication in the pharmaceutical industry. Over the years, he has focused on the development of drugs that can significantly improve patient care, particularly through the inhibition of critical pathways in disease progression.

Collaborations

Throughout his career, Eric Gundersen has collaborated with distinguished colleagues such as Scott Christian Mayer and John Anthony Butera. These collaborations have enriched his research and contributed to the scientific community's understanding of PAI-1 and its implications in various therapeutic settings.

Conclusion

In summary, Eric Gould Gundersen has established himself as an influential inventor with a keen focus on developing innovative compounds for medical applications. His contributions, particularly in the area of PAI-1 inhibition, underline the importance of research and innovation in creating effective treatments for complex health challenges. With 13 patents to his name, Gundersen continues to inspire future generations of inventors in the biopharmaceutical sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…